Development of a Telehealth Screener and Assessment for Infants at-risk for ASD in Diverse Communities.
Development of a Telehealth Screener and Assessment for Infants at-risk for ASD in Diverse Communities.
批准号:
10024067
负责人:
Meagan Ruth Talbott
金额:
$19.63万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2022-08-31
关键词:
AddressAgeAge-MonthsBehavioralBenchmarkingBiological MarkersCaregiversCollectionCommunicationCommunitiesCountryDataDevelopmentDiagnosticDisciplineEarly identificationEligibility DeterminationEnsureEvaluationFamilyFeasibility StudiesFeedbackFundingFutureGeographyGoalsGrowthHealth Services AccessibilityHome environmentInfantInfant BehaviorInfant DevelopmentInterventionIntervention TrialLifeMeasuresMediatingMethodsModelingMonitorNeurobiologyOutcomeParentsPhaseProtocols documentationPublicationsRandomizedReportingResearch PersonnelResourcesRiskRuralSamplingScientistScreening procedureServicesSiblingsSymptomsSystemTestingTrainingTravelUniversitiesValidity and ReliabilityVisitVulnerable PopulationsWait TimeWaiting Listsagedautism spectrum disorderautistic childrenbasecommunity based participatory researchcommunity settingcontrol trialcostcost effectivedisorder riskfield studyhigh risk infanthigh risk populationimprovedlongitudinal analysismeetingsprospectiverecruitroutine screeningsatisfactionscreeningsocial communicationstandardize measuretelehealth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The overall goal of this proposal is to develop a telehealth procedure for screening infants 6-12
months of age for early autism spectrum disorder (ASD) symptoms. While some promising
biomarkers have been identified for infants in this age range, neurobiological methods are not
feasible for widespread implementation, especially in rural and low-resource service systems.
Families with early concerns are faced with long waitlists for an evaluation and often must travel
long distances for evaluations at centers with appropriate expertise. Telehealth has been used
as a cost-effective approach for increasing access to services across many disciplines, and
there is some initial use of telehealth treatment approaches in ASD, but there are currently no
established telehealth screening procedures to screen infants for ASD. Developing a telehealth
screening protocol would provide families an opportunity to access highly trained clinicians and
researchers with specialized expertise for initial screening before undertaking the cost and effort
required to travel to a center. The first six months of funding will be used to develop, refine, and
pilot test this parent-administered protocol in a sample of diverse infants 6-12 months (Aim 1).
Feedback from parents and experts will inform final adaptations. The resulting protocol will
subsequently be tested via telehealth in a pilot feasibility phase (Aim 2). 30 infants 6-12 months
with early ASD symptoms and their caregivers will be recruited nationally, and will complete the
telehealth screener quarterly for one year. We will examine the reliability of telehealth-derived
measures of infant behavior across consecutive administrations, and compare these measures
to existing parent-report measures to assess their validity. Acceptability to parents and feasibility
of this telehealth approach to screening will also be evaluated. The overall goal of this project is
to develop a protocol for systematically screening, assessing, and monitoring symptomatic
infants from a distance. Doing so will increase families' access to specialized evaluations and
decrease the significant waiting time between parents' first concerns and infants' first
evaluation. It will also lay the groundwork for future efforts to conduct screening and intervention
trials and will ultimately help to increase access to high-quality interventions and improve the
developmental outcomes of many more underserved children with ASD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
-
批准号:10805226
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2023
-
负责人:Meagan Ruth Talbott
-
依托单位:
Leveraging Telehealth to Identify Infants at Elevated Likelihood for Autism in the First Year of life
-
批准号:10712632
-
项目类别:
-
资助金额:$64.31万
-
财政年份:2023
-
负责人:Meagan Ruth Talbott
-
依托单位:
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
-
批准号:10373091
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2021
-
负责人:Meagan Ruth Talbott
-
依托单位:
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
-
批准号:10196622
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2021
-
负责人:Meagan Ruth Talbott
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: